​This is a clinical research program including 2 identical studies which, together, are called the 601/602 Pediatric Autism Study. The study will help us understand more about a potential new (investigational) medication (“study drug”) for irritability in children and teenagers with autism.

 

It is hoped that the study drug will:

• help restore the balance of chemicals in the brain (dopamine, serotonin, and glutamate) that are important for regulating mood, and

•  reduce the severity of irritability and behaviors associated with it.

 

​

​

• 5–17 years of age* with a diagnosis of ASD

• experiencing irritability, such as tantrums, aggression, yelling, or self-harming behavior.

• We are currently only looking for teenagers who are 13–17 years of age. Younger children will be invited to take part later.

​

​

​

• Study related care from a local pediatric neurologist at no cost to you.

• Study medication at no cost to you

• Volunteers who take part in the study may be compensated for their travel costs and their time in the study.